Jennifer Mendiolina

Use of Relative Ratio to analyze Donor Specific Antibody – One center’s experience

P021 : DTT CAN UNCOVER HIDDEN UAS

P005 : LOW LEVEL ANTI-HLA ANTIBODIES: DETERMINING RELEVANT UNACCEPTABLE ANTIGENS BY SINGLE ANTIGEN MICROARRAY AND SPECIFIC/SURROGATE FLOW CROSSMATCHES

P030 : THE EFFECTS OF HYPOTONIC DIALYSIS AND SPIN COLUMNS ON SERUM ANTI-HLA IgG LEVELS

Positive Flow Crossmatches in Renal Patients Without "Detectable" Antidonor HLA Antibodies: Maximizing Renal Transplant Rate by Decreasing False Positives Crossmatches

33-P: A NEW WAY TO QC DTT

10-P : SELECTION OF APPROPRIATE HUMAN SERA FOR NEGATIVE CONTROLS IN FLOW CROSSMATCHING TO DETERMINE RENAL TRANSPLANTATION COMPATIBILITY

13-P: INCREASED RENAL TRANSPLANTS FOR SENSITIZED RECIPIENTS FOLLOWING VIRTUAL CROSSMATCH INTRODUCTION: ONE CENTER’S EXPIERIENCE

69-P: EFFICIENT C1q LUMINEX TESTING BY INITIALLY SCREENING FOR DONOR SPECIFIC ANTIBODY BY THE SINGLE ANTIGEN LUMINEX ASSAY

49-P How much is too much